Make Pregnancy Drug Content Exceptions Clear to Uphold Free Expression
29 de Outubro de 2026
In restoring an Instagram video of a woman describing her experience with prescription fentanyl during childbirth, the Oversight Board recommends Meta take steps to ensure correct enforcement of existing medical exceptions to policies covering illicit drugs, and further protection of the free expression rights around sharing pregnancy and maternal health information.
Why This Matters
Social media is a vital source of pregnancy and maternal health information globally for people seeking guidance and peer support, including sharing their experiences with prescription drugs. Overenforcement of Meta’s community standards on drug-related maternal health content is a widely documented problem that suppresses well-intentioned personal storytelling and maternal health advocacy. At the same time, there has been a worldwide proliferation of drug use and trafficking. In the United States, where this case originates, there is an opioid crisis. Illicit fentanyl use is the primary driver of overdose deaths in the country, and moderating content related to illegal drugs is a serious concern for platforms.
About the Case
In February 2026, an Instagram user posted a 20-second video and caption describing the side effects she experienced from several types of prescription drugs used to treat nausea and vomiting during her pregnancy. She also described her experience with pain relief medication, including fentanyl, which was clinically administered during labor. In the post, she said that fentanyl is “on my permanent no list” because the drug made her confused. The video features imagery with memes and short, humorous movie clips representing how each medication affected her during her pregnancy.
After automatic detection and multiple, separate human reviews, Meta removed the post under its Restricted Goods and Services policy, which prohibits content that admits to personal use of “high-risk drugs,” including fentanyl, unless there is acknowledgement of or reference to recovery, treatment or other assistance to combat usage. In addition, Meta applied a strike and a time-based feature limit to the user’s account.
The user appealed Meta’s decision to the Board. When the Board brought the case to Meta’s attention, the company determined that the decision to remove the post was an error, noting that the Restricted Goods and Services policy allows exceptions for admitting to the use of a prescription drug, which fentanyl can also be. Meta restored the post and reversed the strike on the user’s account, although the post remains restricted to adults and is ineligible for recommendation.
Key Findings
The Board finds that the video in this case did not violate the Restricted Goods and Services policy because the reference to fentanyl falls under the policy exceptions for posting about prescription drugs in a medical context. Although fentanyl is listed as a “high-risk” drug under the policy, and posts can be removed if referencing fentanyl in an illicit context, discussing the medical merits of the drug when it is prescribed is allowed.
The Board also finds that restricting the content in this case to users over 18-years-old and making it ineligible for recommendation is inconsistent with Meta’s human rights responsibilities, specifically the freedom of users, including minors, to seek and receive health-related information.
The case raises serious concerns about accuracy in enforcing the Restricted Goods and Services policy, a point the Board has made repeatedly in past cases. Multiple human reviewers assessed the content and did not reach the correct conclusion. The Board notes that human reviewers are interpreting policies too rigidly, without fully taking into account the wider context. There is a further concern that the guidelines reviewers are following are insufficiently clear for them to make correct decisions based on context.
The Board also has concerns about the impact erroneous account restrictions can have on people and organizations that advocate for reproductive and maternal health globally on social media. The Board calls on Meta to include global reproductive and maternal health organizations in the Sensitive Entity Secondary Review system that currently gives additional protections to journalists, rights defenders and dissidents. It also urges Meta to conduct a global audit to determine the extent to which enforcement of the Restricted Goods and Services policy is disproportionately removing maternal health-related content.
The Oversight Board’s Decision
The Board overturns Meta's original decision to take down the content. The content should have been left up without the age-gating restriction and should not have been made non-recommendable.
The Board recommends that Meta:
- Clarify the Restricted Goods and Services Community Standard to state expressly that admissions of personal use of a drug administered by medical professionals – including substances otherwise designated high-risk – are treated under the prescription drug allowance.
- Align internal guidance and external language of the Restricted Goods and Services policy to clarify that admissions of use of high-risk drugs do not violate the policy in all cases when such drugs also exist in pharmaceutical form, such as fentanyl. Meta should ensure that these policy materials consistently emphasize the role of medical context in determining which form of a drug is at issue, and that, with respect to internal guidance, reviewers are empowered to consider medical context when distinguishing between different types of drugs. The internal guidance should also clarify what signals indicate medical context.
- Ensure that global reproductive and maternal health organizations are deemed eligible for enrollment as part of the broader set of entities protected for human rights reasons in the Sensitive Entity Secondary Review system.
- Audit global enforcement of the Restricted Goods and Services Community Standard against content discussing the medical use of drugs, publish category-level error rates broken down by region, country or language, and assess whether errors fall disproportionately on reproductive, maternal and women's health content. This audit should also assess the impact of the standard's 18+ years age restriction on the ability of under-18-year-old users to access health information relevant to them.
Futher Information
To read public comments for this case, click here.
